LAWTON ALISON FRANCES received a stock award from X4 PHARMACEUTICALS, INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/27/2022ACC: 0001628280-22-018054
Director
Since Oct 2020
+6.67K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
6.67K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+6.67K
Price / share
—
Trade value
—
% of position
New position
6/6/2022
0.00→6.67K
Total
Net shares
+6.67K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/6/2022 | A · Award | +6.67K | — | — | New position | 0.00 | 6.67K |
| Total | +6.67K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported